| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | Details | |
| Nesiritide | BNP-32 (human); JNS-004; hBNP; SC-70400 | Phase 2 Clinical | Johnson & Johnson | Myocardial Ischemia; Hyperemia; Heart Failure; Renal Insufficiency; Acutely decompensated congestive heart failure; Sleep Disorders, Circadian Rhythm; Hypertension; Dyspnea; Coronary Disease; Cardiomyopathies; Hyperinsulinism; Cardiovascular Diseases; Obesity; Diabetes Mellitus; Heart Failure, Systolic | Details |
| PL-3994 | PL-3994 | Phase 2 Clinical | Palatin Technologies Inc | Heart Failure; Hypertension; Asthma | Details |
| REGN-7544 | REGN-7544; REGN7544 | Phase 2 Clinical | Hypotension; Postural Orthostatic Tachycardia Syndrome | Details | |
| XXB-750 | XXB-750 | Phase 2 Clinical | Novartis Pharma Ag | Heart Failure; Hypertension; Heart Failure, Systolic | Details |
| GNP | Phase 2 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| REGN-5381 | REGN-5381 | Phase 2 Clinical | Heart Failure | Details | |
| Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Phase 1 Clinical | Suzhou RxD Biopharmaceutical Co Ltd | Heart Failure | Details | |
| Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 1 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Heart Failure; Acutely decompensated congestive heart failure | Details | |
| Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Hypotension; Heart Failure; Schizophrenia; Myocardial Infarction; Hypertension; Pulmonary Edema | Details |
| Carperitide | SUN-4936; SUN-4936h; SUN-4936r; SUN-Y4936r; alpha-hANP; ANF (99-126); ANP (99-126); CDD (99-126) | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Heart Failure; Respiratory Distress Syndrome, Adult; Cardiomyopathies | Details |




